Michael Owen

Michael John Owen was the founder of Kymab Ltd., founded in 2010, where the title held was Chief Scientific Officer from 2010 to 2011.
Current jobs include Chairman at Ossianix, Inc. since 2013; Non-Executive Director at Sareum Holdings Plc since 2018; Director at ReNeuron Ltd. since 2000; Director at Gammadelta Therapeutics Ltd.; Senior Independent Director at Avacta Life Sciences Ltd.; Non-Executive Director at The Club Cricket Organisation Ltd.; Director at Ossianix Uk Ltd.; Non-Executive Director at Novalgen Ltd. since 2023; Member at The European Molecular Biology Laboratory; and Member at European Molecular Biology Organization.
Former jobs include Non-Executive Director at Istesso Ltd.; Senior Independent Director at Avacta Group Plc from 2015 to 2021; Director at Iksuda Therapeutics Ltd.; Non-Executive Director at BliNK Therapeutics Ltd.; Director at BliNK Biomedical SAS; Independent Director at Zealand Pharma A from 2012 to 2024; Independent Non-Executive Director at ReNeuron Group Plc from 2015 to 2025; Senior VP & Head-Biopharmaceuticals Research at GSK Plc from 2001 to 2010; and Member at Apollo Therapeutics No.
2 LLP.
Education includes graduate degree from the University of Oxford and doctorate from the University of Cambridge conferred in 1976.